{
	"slug": "pneumonia-severity",
	"title": "Pneumonia Risk Stratification Tools",
	"authors": [
		"Michelle Lin, MD"
	],
	"categories": [
		{
			"slug": "pulmonology",
			"name": "Pulmonology"
		},
		{
			"slug": "infectious-disease",
			"name": "Infectious Disease"
		},
		{
			"slug": "ebm",
			"name": "EBM"
		}
	],
	"created": "2011/02/25",
	"updates": null,
	"body": "\n# Pneumonia: Risk Stratification Scoring Tools\n\n## Pneumonia Severity Index (PSI) \n\n[Fine et al., JAMA 1997](http://www.ncbi.nlm.nih.gov/pubmed/?term=8995086)\n- Pneumonia Patient Outcomes Research Team (PORT)\n- A large derivation and validation study with >50,000 patients\n- Best identifies low-risk/ low-mortality patients\n- Tends to miss higher-risk pneumonia in younger patients because score is based on age \n- Does not factor in immunosuppression (eg. HIV) and poor social support \n\n| Risk factors                           |         Points |\n| -------------------------------------- | -------------: |\n| Men                                    |    Age (years) |\n| Women                                  | Age (years)-10 |\n| Nursing home resident                  |            +10 |\n| History of neoplasm                    |            +30 |\n| History of liver disease               |            +20 |\n| History of heart failure               |            +10 |\n| History of stroke                      |            +10 |\n| History of renal failure               |            +10 |\n| Altered mental status                  |            +20 |\n| RR &ge; 30 breaths/ min                |            +20 |\n| SBP &lt; 90 mmHg                       |            +20 |\n| Temp &lt; 95F (35C) or &ge;104F (40C)  |            +15 |\n| HR &ge; 125 bpm                        |            +10 |\n| Arterial pH &lt; 7.35                  |            +30 |\n| BUN &gt; 30 mg/dL                      |            +20 |\n| Na &lt; 130 mmol/L                     |            +20 |\n| Glucose &ge;250 mg/dL                  |            +10 |\n| Hematocrit &lt; 30%                    |            +10 |\n| PaO2 &lt; 60 mmHg                      |            +10 |\n| Pleural effusion                       |            +10 |\n\n| PSI Class | Total Points | 30-Day Mortality | Disposition                        |\n| --------- | -----------: | ---------------: | ---------------------------------- |\n| I         |      &lt; 51 |             0.1% | Outpatient                         |\n| II        |        51-70 |             0.6% | Outpatient                         |\n| III       |        71-90 |             0.9% | Outpatient vs short-stay inpatient |\n| IV        |       91-130 |             9.3% | Inpatient                          |\n| V         |     &gt; 130 |            27.0% | Inpatient ICU                      |\n\n## CURB-65 Severity Score\n\nSupported by ([British Thoracic Society Standards of Care Committee](http://www.ncbi.nlm.nih.gov/pubmed/?term=11713364) &[ ](http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136)[Aujesky et al, Am J Med, 2005](http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136)) \n\n- Best identifies high-risk/ high-mortality patients\n- Tends to misclassify moderate-risk pneumonia patients (as low-risk) \n- Does not account for co-morbidities and hypoxemia\n\n|        | Risk Factor                                     | Points |\n| ------ | ----------------------------------------------- | -----: |\n| **C**  | **C**onfusion                                   |      1 |\n| **U**  | Uremia (BUN >19 mg/dL)                          |      1 |\n| **R**  | **R**R &ge; 30 breaths/min                      |      1 |\n| **B**  | **B**P low (SBP &lt;90 mmHg or DBP &lt;60 mmHg) |      1 |\n| **65** | Age &ge; **65** years                           |      1 |\n\n| Total Points | 30-Day Mortality | Disposition                        |\n| -----------: | ---------------: | ---------------------------------- |\n|            0 |             0.6% | Outpatient                         |\n|            1 |             3.2% | Outpatient                         |\n|            2 |            13.0% | Outpatient or short-stay inpatient |\n|            3 |            17.0% | Inpatient                          |\n|            4 |            41.5% | Inpatient, likely ICU              |\n|            5 |            57.0% | Inpatient ICU                      |\n\n## SMART-COP\n\nSupported by Australian CAP Study ([Charles et al., Clin Infect Dis, 2008](http://www.ncbi.nlm.nih.gov/pubmed/?term=18558884))\n\n- Tool to predict need for intensive respiratory or vasopressor support (IRVS) \n\n<table>\n<colgroup>\n<col width=\"33%\" />\n<col width=\"33%\" />\n<col width=\"33%\" />\n</colgroup>\n<thead>\n<tr class=\"header\">\n<th><br />\n</th>\n<th><strong>Risk factor</strong></th>\n<th><strong>Points</strong></th>\n</tr>\n</thead>\n<tbody>\n<tr class=\"odd\">\n<td><strong>S</strong></td>\n<td><strong>S</strong>ystolic BP &lt; 90 mmHg</td>\n<td>2</td>\n</tr>\n<tr class=\"even\">\n<td><strong>M</strong></td>\n<td><strong>M</strong>ultilobar CXR involvement</td>\n<td>1</td>\n</tr>\n<tr class=\"odd\">\n<td><strong>A</strong></td>\n<td><strong>A</strong>lbumin &lt; 3.5 g/dL</td>\n<td>1</td>\n</tr>\n<tr class=\"even\">\n<td><strong>R</strong></td>\n<td>If age &le; 50 years: <strong>R</strong>R &ge; 25 breaths/min <br />\nIf age &gt; 50 years: <strong>R</strong>R &ge; 30 breaths min <br />\n</td>\n<td>1</td>\n</tr>\n<tr class=\"odd\">\n<td><strong>T</strong></td>\n<td><strong>T</strong>achycardia HR &ge; 125 bpm </td>\n<td>1</td>\n</tr>\n<tr class=\"even\">\n<td><strong>C</strong></td>\n<td><strong>C</strong>onfusion (new onset)</td>\n<td>1<br />\n</td>\n</tr>\n<tr class=\"odd\">\n<td><strong>O</strong></td>\n<td><strong>O</strong>xygen low<br />\n\n<p>If age &le;50 years: </p>\n<ul>\n<li>PaO2 &lt; 70 mmHg, or<br />\n</li>\n<li>O2 sat &le; 93%, or<br />\n</li>\n<li>PaO2/FiO2 &lt; 333<br />\n</li>\n</ul>\n<p>If age &gt;50 years:</p>\n<ul>\n<li>PaO2 &lt; 60 mmHg, or</li>\n<li>O2 sat &le; 90%, or </li>\n<li>PaO2/FiO2 &lt; 250 </li>\n</ul></td>\n<td>2</td>\n</tr>\n<tr class=\"even\">\n<td><strong>P</strong></td>\n<td>Arterial <strong>p</strong>H &lt; 7.35</td>\n<td>2</td>\n</tr>\n</tbody>\n</table>\n\n| Total points | Risk of needing IRVS |\n| -----------: | -------------------- |\n|          0-2 | Low                  |\n|          3-4 | Moderate (1 in 8)    |\n|          5-6 | High (1 in 3)        |\n|       &ge; 7 | Very high (2 in 3)   |\n\n## References\n\n- Aujesky D et. al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. _Am J Med_. 2005 Apr;118(4):384-92. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/?term=15808136)]\n- Fine MJ et. al. A prediction rule to identify low-risk patients with community-acquired pneumonia. _N Engl J Med_. 1997 Jan 23;336(4):243-50. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/?term=8995086)]\n- Charles PG et. al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. _Clin Infect Dis_. 2008 Aug 1;47(3):375-84. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/?term=18558884)]\n- British Thoracic Society Standards of Care Committee. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. _Thorax_. 2001 Dec;56 Suppl 4:IV1-64. [[PubMed](http://www.ncbi.nlm.nih.gov/pubmed/?term=11713364)]\n"
}